Press Releases

All Releases
View Summary Ophthotech Corporation Announces Closing of Registered Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Feb 18, 2014
PDF 8.0 KB Add to Briefcase
View Summary Ophthotech Corporation Announces Pricing of Public Offering of Common Stock
Feb 11, 2014
PDF 7.8 KB Add to Briefcase
View Summary Ophthotech Corporation Announces Proposed Public Offering of Common Stock
Feb 10, 2014
PDF 7.7 KB Add to Briefcase
View Summary Ophthotech Corporation Receives $41.7 Million in Second Tranche in Royalty Financing from Novo A/S
Jan 24, 2014
PDF 10.7 KB Add to Briefcase
View Summary Ophthotech Corporation to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2014
PDF 7.2 KB Add to Briefcase
View Summary Ophthotech Reports Third Quarter 2013 Financial Results and Provides Business and Product Development Update
Nov 13, 2013
PDF 646.4 KB Add to Briefcase
View Summary Ophthotech to Report Third Quarter 2013 Results and Host Conference Call on Wednesday, November 13, 2013
Oct 30, 2013
PDF 7.5 KB Add to Briefcase
View Summary Ophthotech Closes Initial Public Offering
Sep 30, 2013
PDF 7.0 KB Add to Briefcase
View Summary Ophthotech Corporation Prices Initial Public Offering
Sep 24, 2013
PDF 7.3 KB Add to Briefcase
View Summary Ophthotech Enrolls First Patient in Phase 3 Clinical Trial of Fovista™ Anti-PDGF Therapy in Combination with Anti-VEGF Therapy for Wet AMD
Aug 29, 2013
PDF 7.8 KB Add to Briefcase
View Summary Ophthotech Corporation Files Registration Statement for Proposed Initial Public Offering
Aug 15, 2013
PDF 7.3 KB Add to Briefcase
View Summary Funding to Develop the First Therapy to Show Superior Efficacy Over the Current Standard of Care
May 29, 2013
PDF 46.4 KB Add to Briefcase
View Summary Ophthotech to Present at 31st Annual J.P. Morgan Healthcare Conference
Jan 3, 2013
PDF 8.4 KB Add to Briefcase
View Summary Positive Results from Phase 2b Study of Ophthotech’s Novel Anti-PDGF Combination Agent Fovista™ to be Presented at AAO Retina Subspecialty Day
Oct 24, 2012
PDF 10.5 KB Add to Briefcase
View Summary Ophthotech’s Novel Anti-PDGF Combination Agent Fovista™ Demonstrated Superior Efficacy over Lucentis® Monotherapy in Large Controlled Wet AMD Trial
Jun 13, 2012
PDF 12.5 KB Add to Briefcase
View Summary Ophthotech to Present at 30th Annual J.P. Morgan Healthcare Conference
Jan 3, 2012
PDF 8.1 KB Add to Briefcase
Showing 81-96 of 96 Page: 1 2 3 4 5  Previous 20
Showing 81-96 of 96
Page: 1 2 3 4 5
 Previous 20
Add to Briefcase = add release to Briefcase